Metrion Biosciences Closes Funding Round • Includes investment from o2h Ventures Therapeutics Fund • Funding to support expansion of ion channel screening capabilities and continued research into potential drugs for auto-immune diseases Cambridge, UK, 01 April 2019: Metrion Biosciences Ltd (“Metrion”), the specialist ion channel contract research and drug discovery company, announced today that it […]Read More